Mobile Platform for Opioid Use Disorder and Alcoholism
(MPOWER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist individuals with both opioid and alcohol use disorders. It employs a digital platform that provides support and rewards to encourage adherence to treatment and sobriety. Participants will be divided into two groups: one will use a digital program focused on motivation and support (Digital Contingency Management Intervention Arm), while the other will use a wellness platform offering resources like surveys and tech support (Digital Wellness Arm). Individuals who have been on specific opioid treatments, have alcohol use issues, are on Michigan Medicaid, and possess a smartphone may be suitable candidates. As an unphased trial, this study presents a unique opportunity to contribute to innovative research that could influence future treatment options.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be on opioid agonist treatment with buprenorphine or methadone to participate.
What prior data suggests that this digital platform is safe for treating opioid and alcohol use disorders?
Research has shown that digital contingency management (CM) is generally well-received by people with substance use disorders. Studies have found that digital CM tools can help patients adhere to their treatment plans and reduce substance use. For instance, one study found that patients using a digital CM tool had 35% fewer days of opioid use.
Few reports of serious side effects or negative events with digital CM suggest it is a safe option for those seeking help for opioid and alcohol use disorders. Digital platforms for treatment also provide extra convenience and support, making it easier for participants to stay engaged in their recovery.
While the safety data appears promising, staying informed and discussing any concerns with healthcare providers before joining a trial is always important.12345Why are researchers excited about this trial?
Researchers are excited about these digital interventions for opioid use disorder and alcoholism because they offer a novel approach to treatment through technology. The Digital Contingency Management Intervention Arm uses a comprehensive digital platform that not only supports motivation but also aims to improve retention in opioid agonist therapy (OAT) and encourage abstinence from substances. This contrasts with traditional treatments like medication-assisted therapy and counseling by integrating behavioral incentives with digital tools. Meanwhile, the Wellness Condition offers participants a unique digital platform focusing on wellness through surveys and tech support, which could enhance user engagement and accessibility. These digital solutions have the potential to reach more people more conveniently, providing a personalized and supportive experience.
What evidence suggests that this trial's treatments could be effective for opioid and alcohol use disorders?
Research shows that digital contingency management (CM), which participants in this trial may receive, can help treat substance use disorders. Studies have found that people using digital CM apps like DynamiCare are more likely to stay away from drugs and alcohol than those who don't use these apps. Digital CM offers rewards for staying drug-free, boosting motivation and accountability. Results from similar patient groups showed that those using digital CM had much better outcomes. This method holds promise for helping people with opioid and alcohol use disorders achieve and maintain recovery. Meanwhile, another group in this trial will receive a wellness digital platform, which includes surveys, testing, and tech support, to compare its effectiveness.23678
Who Is on the Research Team?
Anne Fernandez, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for people with opioid and alcohol use disorders who are on Medicaid in Michigan. They must have a stable address, access to a smartphone and internet, be taking OAT (buprenorphine or methadone), and self-report an alcohol disorder. It's not for those who don't understand English, have severe mental health issues, expect to be incarcerated or in residential treatment soon, can't consent themselves, have primary Medicare coverage or significant cognitive impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Assessment
Participants complete the DynamiCare assessment period before randomization
Treatment
Participants receive either the digital CM platform or the wellness digital platform
Follow-up
Participants are monitored for acceptability and feasibility of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Digital Contingency Management Intervention Arm
- Digital Wellness Arm
Trial Overview
The study tests a digital contingency management treatment designed to help individuals recover from co-occurring opioid and alcohol use disorders. Participants will either receive the digital CM intervention aimed at promoting wellness and engagement in recovery or participate in a digital wellness program without the CM incentives.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
After participants meet eligibility and complete the DynamiCare assessment period, participants randomized to this group will receive a comprehensive digital CM platform designed to enhance OAT retention and promote abstinence from alcohol and opioids. This will include the DynamiCare Motivation Support Program.
After participants meet eligibility and complete the DynamiCare assessment period, those randomized to this group will receive a wellness digital platform that includes surveys, testing, and tech support.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
DynamiCare Health
Industry Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Citations
Digital delivery of a contingency management intervention ...
Digital health tools can provide convenient delivery of evidence-based treatments. The DynamiCare Health smartphone app delivers a ...
Digital Contingency Management for Substance Use Disorder ...
Results: Two cohorts of propensity-matched patients (66 interventions and 59 controls) were analyzed. Abstinence was significantly higher in the ...
Contingency Management Reports — DynamiCare Health
Contingency Management (CM) is a behavioral intervention for substance use disorders that combines motivation and accountability by leveraging the power of ...
Digital Contingency Management for Substance Use ...
Two cohorts of propensity-matched patients (66 interventions and 59 controls) were analyzed. Abstinence was significantly higher in the DCM ...
5.
recoveryanswers.org
recoveryanswers.org/research-post/contingency-management-app-exploring-feasibility-automated-digital-contingency-management-substance-use-disorder/Technology-enhanced contingency management
In this study, researchers explored the feasibility of a digital contingency management intervention for substance use disorder delivered via a smartphone app ...
Digitally delivered contingency management during ...
People in treatment for opioid use disorder (OUD) who also use cocaine are at heightened risk of early treatment discontinuation and poor ...
7.
weconnecthealth.io
weconnecthealth.io/blog/enhancing-opioid-use-disorder-treatment-with-app-based-contingency-managementEnhancing Opioid Use Disorder Treatment with App-Based ...
A recent JAMA Network Open study found that patients who used WEconnect alongside their MOUD treatment had 35% fewer days of opioid use and ...
Engagement patterns with a digital therapeutic for ...
206 patients with substance use disorder (SUD) were exposed over 12 weeks to a digital therapeutic (TES). · Number of TES modules completed was correlated with ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.